Diabeloop Announces CE Marking and Gradual Launch of the New DBLG2 System, Integrated with Dexcom G7 CGM and ViCentra’s Kaleido Insulin Delivery System

Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announced technical readiness, CE marking approval and the gradual European launch of its latest Automated Insulin Delivery (AID) system, DBLG2, integrated with Dexcom G7 Continuous Glucose Monitoring (CGM) system.